Xeris Biopharma Holdings, Inc. (XERS)
8.525
-0.06
(-0.76%)
USD |
NASDAQ |
Sep 04, 16:00
8.525
0.00 (0.00%)
After-Hours: 20:00
Xeris Biopharma Holdings Cash from Investing (Quarterly) : -0.209M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.209M |
| March 31, 2026 | -0.325M |
| December 31, 2025 | -0.333M |
| September 30, 2025 | -0.071M |
| June 30, 2025 | -0.279M |
| March 31, 2025 | -0.013M |
| December 31, 2024 | 10.02M |
| September 30, 2024 | 9.914M |
| June 30, 2024 | 4.603M |
| March 31, 2024 | -19.65M |
| December 31, 2023 | 14.87M |
| September 30, 2023 | 14.66M |
| June 30, 2023 | 8.452M |
| March 31, 2023 | -43.98M |
| December 31, 2022 | 9.168M |
| September 30, 2022 | 6.709M |
| June 30, 2022 | 11.87M |
| March 31, 2022 | 6.716M |
| December 31, 2021 | 36.60M |
| Date | Value |
|---|---|
| September 30, 2021 | 18.50M |
| June 30, 2021 | 16.56M |
| March 31, 2021 | 26.30M |
| December 31, 2020 | 7.249M |
| September 30, 2020 | -60.67M |
| June 30, 2020 | 17.34M |
| March 31, 2020 | 8.676M |
| December 31, 2019 | -9.041M |
| September 30, 2019 | -2.496M |
| June 30, 2019 | 27.88M |
| March 31, 2019 | -18.72M |
| December 31, 2018 | -11.72M |
| September 30, 2018 | -56.05M |
| June 30, 2018 | -0.156M |
| March 31, 2018 | -0.333M |
| December 31, 2017 | -0.236M |
| September 30, 2017 | -0.025M |
| June 30, 2017 | -0.097M |
| March 31, 2017 | -0.342M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Zevra Therapeutics, Inc. | 31.45M |
| Aclaris Therapeutics, Inc. | 10.26M |
| ANI Pharmaceuticals, Inc. | -3.054M |
| Corcept Therapeutics, Inc. | -29.24M |
| Veru, Inc. | 1.802M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 8.263M |
| Cash from Financing (Quarterly) | 1.943M |
| Free Cash Flow | 55.67M |
| Free Cash Flow Per Share (Quarterly) | 0.0466 |
| Free Cash Flow to Equity (Quarterly) | -22.84M |
| Free Cash Flow to Firm (Quarterly) | 15.00M |
| Free Cash Flow Yield | 3.69% |